ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Adarx Pharmaceuticals, inc
12.79
-1.3700
-9.68%
盘后:
12.79
0.0000
0.00%
19:58 EST
成交量:
70.88万
成交额:
961.76万
市值:
14.22亿
市盈率:
-13.98
高:
14.87
开:
14.03
低:
12.63
收:
14.16
52周最高:
23.21
52周最低:
12.50
股本:
1.11亿
流通股本:
1.02亿
量比:
1.12
换手率:
0.69%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.9150
每股收益(LYR):
-7.5365
净资产收益率:
-38.89%
总资产收益率:
-14.90%
市净率:
2.48
市盈率(LYR):
-1.70
数据加载中...
总览
公司
新闻资讯
公告
数据简报-冷热不一的开局:2026年美国主要IPO上市首日表现如何
路透中文
·
11/20
摩根士丹利首予Adarx Pharmaceuticals“增持”评级 目标价32美元
美股速递
·
10/21
美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy
路透中文
·
10/20
美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy
路透中文
·
10/20
ADARx Pharmaceuticals在扩大IPO规模后,纳斯达克首日上市股价飙升
路透中文
·
09/26
ADARx制药公司通过规模扩大的美国首次公开募股(IPO)筹集了4.463亿美元
路透中文
·
09/25
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/ADRX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","market":"US","secType":"STK","nameCN":"Adarx Pharmaceuticals, inc","latestPrice":12.79,"timestamp":1795208400000,"preClose":14.16,"halted":0,"volume":708825,"hourTrading":{"tag":"盘后","latestPrice":12.79,"preClose":12.79,"latestTime":"19:58 EST","volume":714,"amount":9082.66,"timestamp":1795222692995,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0967514124293786,"floatShares":102200905,"shares":111193446,"eps":-0.915,"marketStatus":"休市中","change":-1.37,"latestTime":"11-20 16:00:00 EST","open":14.03,"high":14.87,"low":12.63,"amount":9617550.956325,"amplitude":0.158192,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.915,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1795424400000},"marketStatusCode":7,"adr":0,"listingDate":1790308800000,"exchange":"NASDAQ","adjPreClose":14.16,"preHourTrading":{"tag":"盘前","latestPrice":14.32,"preClose":14.16,"latestTime":"07:30 EST","volume":5,"amount":71.6,"timestamp":1795177828755,"change":0.16,"changeRate":0.011299,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.79,"preClose":12.79,"latestTime":"19:58 EST","volume":714,"amount":9082.66,"timestamp":1795222692995,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1205744957995711},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","floatShares":102200905,"roa":"-14.90%","roe":"-38.89%","lyrEps":-7.536516,"volumeRatio":1.1205744957995711,"shares":111193446,"dividePrice":0,"high":14.87,"amplitude":0.158192,"preClose":14.16,"low":12.63,"week52Low":12.5,"pbRate":"2.48","psRate":"209.48","week52High":23.21,"institutionHeld":0,"latestPrice":12.79,"eps":-0.915,"divideRate":0,"volume":708825,"delay":0,"ttmEps":-0.915,"open":14.03,"prevYearClose":17,"prevWeekClose":14.2,"prevMonthClose":17,"prevQuarterClose":19.94,"fiveDayClose":14.2,"twentyDayClose":17.63,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-11-12","symbol":"ADRX","fiscalQuarterEnding":"2026/09","expectedEps":-0.4,"name":null,"time":"盘后","type":"earning","dateTimestamp":1794459600000,"reportTimeType":"post","actualEps":-1.74}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":5,"updateTime":1792645200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADRX","date":"2026-11-20","current":-13.978142,"percent":0.974359,"low":-25.428632,"twenty":-23.151023,"median":-22.49554,"eighty":-17.296784,"high":-14.530498,"avg":-21.023906,"sd":2.940033,"marketCap":1574499195},"quantilePoints":[{"date":"2026-10-02","current":-24.918529,"twenty":-25.150325,"median":-24.918529,"eighty":-24.228516,"marketCap":2189591181},{"date":"2026-10-09","current":-22.540174,"twenty":-24.950973,"median":-23.993968,"eighty":-23.126792,"marketCap":1980605124},{"date":"2026-10-16","current":-22.508293,"twenty":-24.51837,"median":-23.273447,"eighty":-22.56568,"marketCap":1977803702},{"date":"2026-10-23","current":-22.482788,"twenty":-24.318588,"median":-22.654947,"eighty":-22.503192,"marketCap":1975562565},{"date":"2026-10-30","current":-21.679376,"twenty":-23.814156,"median":-22.737839,"eighty":-22.503192,"marketCap":1904966739},{"date":"2026-11-06","current":-16.871655,"twenty":-23.514264,"median":-22.572056,"eighty":-21.812002,"marketCap":1482512350},{"date":"2026-11-13","current":-19.014088,"twenty":-23.312609,"median":-22.546551,"eighty":-19.065098,"marketCap":1670767886},{"date":"2026-11-20","current":-16.049286,"twenty":-23.151023,"median":-22.49554,"eighty":-17.296784,"marketCap":1574499195}],"updateTime":1795379851255},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADRX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2684906188","title":"数据简报-冷热不一的开局:2026年美国主要IPO上市首日表现如何","url":"https://stock-news.laohu8.com/highlight/detail?id=2684906188","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684906188?lang=zh_cn&edition=fundamental","pubTime":"2026-11-20 01:42","pubTimestamp":1795110125,"startTime":"0","endTime":"0","summary":"数据简报-冷热不一的开局:2026年美国主要IPO上市首日表现如何Pragyan Kalita路透社11月19日-Anthropic公司周四在纳斯达克首次公开募股时,开盘价较发行价高出34.3%,这标志着一家前沿人工智能实验室首次登陆股市,并可能为竞争对手OpenAI明年预期的首次公开募股树立标杆。今年的人工智能热潮推动IPO募资创下历史新高,其中几笔交易筹集了史无前例的巨额资金,尽管对人工智能支出的担忧、债券收益率上升以及加息等因素在下半年放缓了上市步伐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261119:nL3T4701W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBRS","CQTM","MAIR","PSP","GMRS","SPCF","INIO","LOFD","SNK","ANT","SPCH","ADRX","QNT","WQTM","SPCU","PRVT","LYNX","SPCX","BRVE","QTUP","HON","LOFF","STDN","MARS","OZEM","ARXS","DPC","WSPC","BSP","ALMR","AAUM","HAWK","BTGO","SPCG","XE","SPAL","FPS","KLRA","ORBX","BXDC","FRVO","WARP","GPZ","SUJA","VVVV","BX","AGBK","JMKE","CSQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195867639","title":"摩根士丹利首予Adarx Pharmaceuticals“增持”评级 目标价32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195867639","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195867639?lang=zh_cn&edition=fundamental","pubTime":"2026-10-21 18:29","pubTimestamp":1792578548,"startTime":"0","endTime":"0","summary":"摩根士丹利启动对Adarx Pharmaceuticals, Inc.的覆盖,给予“增持”评级,目标价定为32美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676661451","title":"美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2676661451","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676661451?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 17:55","pubTimestamp":1792490144,"startTime":"0","endTime":"0","summary":"美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy路透10月20日-周二,华尔街证券分析师修订了多家在美国上市公司的评级和目标股价,其中包括Axon Enterprise、Williams-Sonoma和Xcel Energy。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nL4T4660LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIOT","NEM","PG","MP","AXON","VKTX","GLXY","RGLD","FRVO","ARLO","SPRE","GLAS","ARHS","ORLY","GILD","MPLX","XEL","ETR","BOKF","HUBB","ZION","EYPT","WSM","HTFL","HTLD","BP","FITB","PLD","WERN","RCL","MARA","WES","BLK","CRWV","ADRX","HUT","NI","SWX","SFM","SR","IRON","MRSH","BILT","MPC","SNPS","HOOD","NCLH","KHC","AORT","PBAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676266145","title":"美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2676266145","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676266145?lang=zh_cn&edition=fundamental","pubTime":"2026-10-20 17:55","pubTimestamp":1792490144,"startTime":"0","endTime":"0","summary":"美国研究综述-Axon Enterprise、Williams-Sonoma、Xcel Energy路透10月20日-周二,华尔街证券分析师修订了多家在美国上市公司的评级和目标股价,其中包括Axon Enterprise、Williams-Sonoma和Xcel Energy。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nL4S4660LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HTFL","RCL","ARHS","ARLO","HOOD","MPC","AORT","MPLX","ADRX","HUT","GLXY","MARA","WES","HTLD","NWMX","ZION","CRWV","SWX","MPL","FITB","AXON","PBAM","FRVO","MP","KHC","ORLY","PLD","GILD","RGLD","BOKF","IRON","RIOT","MRSH","VKTX","WERN","SR","WSM","SNPS","XEL","BLK","SFM","ETR","EYPT","PG","NI","BP","HUBB","GLAS","NEM","NCLH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670266264","title":"ADARx Pharmaceuticals在扩大IPO规模后,纳斯达克首日上市股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2670266264","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670266264?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353308,"startTime":"0","endTime":"0","summary":"更新版 2-ADARx Pharmaceuticals在扩大IPO规模后,纳斯达克首日上市股价飙升在第5、9和10段中添加了分析师评论Pragyan Kalita路透9月25日-周五,ADARx制药公司股价较首次公开募股发行价上涨30%,此前这家处于临床后期阶段的基因疗法开发商通过扩大规模的美国IPO募集了4.463亿美元。ADARx成立于2019年,其试验性药物主要针对与免疫、肾脏、心血管和神经系统相关的疾病。自上市以来,其股价已下跌约21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4S45H0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","ETRA","VHT","LU0310799852.SGD","LU2125909593.SGD","LU0689472784.USD","FHLC","FTXH","TRUH","LU1244550494.USD","SG9999001440.SGD","LU2089984988.USD","LU1291159041.SGD","LU0472753341.HKD","RXL","PJP","LU1732799900.SGD","IYH","SG9999015978.USD","AGNG","IE0004445239.USD","LU0456855351.SGD","ADRX","MEDX","LU1074936037.SGD","IE00BVYPNW00.USD","IE000SO60NU8.SGD","IE0002141913.USD","LU0395794307.EUR","LU0029864427.USD","LU0965509101.SGD","IXJ","LU0661504455.SGD","GLAM","LU2237443978.SGD","LU1548497426.USD","LU2237443895.HKD","LU0211327993.USD","LU0069063385.USD","LU2112291526.USD","XLV","BK4581","PPH","LU1061106388.HKD","LU1057294990.SGD","LU1934455863.HKD","IE000WAW04H5.SGD","LU0289961442.SGD","LU2129689514.USD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423354","title":"ADARx制药公司通过规模扩大的美国首次公开募股(IPO)筹集了4.463亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423354","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423354?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 19:02","pubTimestamp":1790334144,"startTime":"0","endTime":"0","summary":"ADARx制药公司通过规模扩大的美国首次公开募股筹集了4.463亿美元路透9月25日-ADARx制药公司周四表示,其在美国进行的首次公开募股规模有所扩大,共筹集资金4.463亿美元,这反映出投资者对生物技术公司上市的兴趣日益浓厚。成立于2019年的ADARx,其试验性药物主要针对与免疫、肾脏、心血管及神经系统相关的疾病。ADARx表示,制药商艾伯维ABBV.N已同意在同期进行的私募配售中投资最高1亿美元,这将使其在IPO后持有约4.9%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4T45H0JH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","IXJ","LU0432979614.USD","LU2129689605.HKD","LU0949170772.SGD","LU2357627491.SGD","LU2237443382.USD","FHLC","LU2237443895.HKD","LU0256863902.USD","LU2468319806.SGD","LU0029864427.USD","ETRA","XLV","JDOC","LU1934455277.USD","AGNG","LU0198837287.USD","LU0211328371.USD","LU0823416689.USD","MEDX","LU0795875169.SGD","IYH","PPH","TRUH","LU0861579265.USD","SG9999015986.USD","LU1074936037.SGD","ADRX","LU2237443978.SGD","LU0708994859.HKD","IE00BLSP4239.USD","LU0912757837.SGD","LU1670627923.USD","RXL","LU0234572021.USD","LU2129689514.USD","GLAM","LU2433249047.HKD","FTXH","LU1244550221.USD","LU1291159041.SGD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1548497426.USD","PJP","IE000SO60NU8.SGD","LU0553294199.USD","LU1496350502.SGD","VHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}